Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-31 @ 12:18 AM
Study NCT ID:
NCT07349303
Status:
RECRUITING
Last Update Posted:
2026-01-21
First Post:
2026-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma
Sponsor:
Organization: